Cheryl T Lee

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi request reprint Impact of body mass index on radical cystectomy
    Cheryl T Lee
    Department of Urology, Michigan Urology Center, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Urol 172:1281-5. 2004
  2. doi request reprint Patient resources available to bladder cancer patients: a pilot study of healthcare providers
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, MI 48109 0946, USA
    Urology 79:172-7. 2012
  3. doi request reprint Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, Michigan 48109 5946, USA
    J Urol 188:2114-9. 2012
  4. ncbi request reprint Racial disparity in bladder cancer: trends in tumor presentation at diagnosis
    Cheryl T Lee
    Departments of Urology and Biostatistics, Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    J Urol 176:927-33; discussion 933-4. 2006
  5. ncbi request reprint Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival
    Cheryl T Lee
    Michigan Urology Center, University of Michigan, Ann Arbor, Michigan, USA
    J Urol 175:1262-7; discussion 1267. 2006
  6. ncbi request reprint A rationale for developing benchmarks for the treatment of muscle-invasive bladder cancer
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA
    Urol Oncol 25:57-65. 2007
  7. ncbi request reprint Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion
    Cheryl T Lee
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Urology 69:1068-72. 2007
  8. ncbi request reprint Orthotopic bladder substitution in women: nontraditional applications
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, Michigan 48109 0330, USA
    J Urol 171:1585-8. 2004
  9. ncbi request reprint Quality of life following incontinent cutaneous and orthotopic urinary diversions
    Cheryl T Lee
    Department of Urology, University of Michigan, 1500 E Medical Center Drive, CCGC 7303, Ann Arbor, MI 48109, USA
    Curr Treat Options Oncol 10:275-86. 2009
  10. ncbi request reprint Bladder cancer facts: accuracy of information on the Internet
    Cheryl T Lee
    Department of Urology, University of Michigan, 1500 E Medical Center Drive, Box 0330, Ann Arbor, MI 48109 0330, USA
    J Urol 170:1756-60. 2003

Detail Information

Publications50

  1. ncbi request reprint Impact of body mass index on radical cystectomy
    Cheryl T Lee
    Department of Urology, Michigan Urology Center, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Urol 172:1281-5. 2004
    ..Morbid obesity may even preclude definitive surgical treatment. This study examines the impact of body mass index (BMI) on radical cystectomy...
  2. doi request reprint Patient resources available to bladder cancer patients: a pilot study of healthcare providers
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, MI 48109 0946, USA
    Urology 79:172-7. 2012
    ..The Institute of Medicine recommends increased resources for cancer survivorship, but no description of current resources exists for bladder cancer patients...
  3. doi request reprint Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, Michigan 48109 5946, USA
    J Urol 188:2114-9. 2012
    ..The primary objective of this study was to estimate the economic and humanistic consequences associated with preventable recurrences in patients initially diagnosed with nonmuscle invasive bladder cancer...
  4. ncbi request reprint Racial disparity in bladder cancer: trends in tumor presentation at diagnosis
    Cheryl T Lee
    Departments of Urology and Biostatistics, Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    J Urol 176:927-33; discussion 933-4. 2006
    ..We examined trends in bladder cancer presentation and survival in white and black patients in a 27-year period to gain additional insight into these factors...
  5. ncbi request reprint Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival
    Cheryl T Lee
    Michigan Urology Center, University of Michigan, Ann Arbor, Michigan, USA
    J Urol 175:1262-7; discussion 1267. 2006
    ..The timing of this delay has been somewhat arbitrary. We evaluated the timing from T2 bladder cancer diagnosis to cystectomy, its impact on survival and potential causes of delay...
  6. ncbi request reprint A rationale for developing benchmarks for the treatment of muscle-invasive bladder cancer
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA
    Urol Oncol 25:57-65. 2007
    ..This article provides a rationale for the development of benchmarks in the treatment of invasive bladder cancer. Such benchmarks may permit advances in treatment application and potentially improve patient outcomes...
  7. ncbi request reprint Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion
    Cheryl T Lee
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Urology 69:1068-72. 2007
    ..We compared the pathologic and survival outcomes of patients with high-risk early-stage disease with those of patients with muscle-invasive tumors at presentation...
  8. ncbi request reprint Orthotopic bladder substitution in women: nontraditional applications
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, Michigan 48109 0330, USA
    J Urol 171:1585-8. 2004
    ..Although successful outcomes have been achieved, groups at most centers have strict selection criteria. We evaluated our experience with female orthotopic diversion in traditional and nontraditional candidates...
  9. ncbi request reprint Quality of life following incontinent cutaneous and orthotopic urinary diversions
    Cheryl T Lee
    Department of Urology, University of Michigan, 1500 E Medical Center Drive, CCGC 7303, Ann Arbor, MI 48109, USA
    Curr Treat Options Oncol 10:275-86. 2009
    ..The choice of urinary diversion still remains a very personal decision to be made between the patient, family members, friends, and the physician...
  10. ncbi request reprint Bladder cancer facts: accuracy of information on the Internet
    Cheryl T Lee
    Department of Urology, University of Michigan, 1500 E Medical Center Drive, Box 0330, Ann Arbor, MI 48109 0330, USA
    J Urol 170:1756-60. 2003
    ..The Internet has a growing number of health web sites and it is a tremendous resource for medical information. We examined the accuracy and completeness of bladder cancer sites on the World Wide Web...
  11. ncbi request reprint Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors
    Cheryl T Lee
    Department of Urology, University of Michigan, 1500 E Medical Center Drive, Box 0330, Ann Arbor, MI 49109, USA
    Urol Oncol 21:179-84. 2003
    ..It may be reasonable to target RCC patients displaying altered bcl-2 levels for molecular therapies, such as anti-bcl2, should metastatic disease develop...
  12. ncbi request reprint Mode of presentation of renal cell carcinoma provides prognostic information
    Cheryl T Lee
    Department of Urology, University of Michigan Hospitals, 1500 E Medical Center Drive, Box 0330, Ann Arbor, MI 48109, USA
    Urol Oncol 7:135-40. 2002
    ..Previous small series have suggested a prognostic benefit for incidental presentation. This study utilizes a large contemporary patient cohort to examine patterns of RCC presentation and their clinical implications...
  13. doi request reprint Multiple adverse histological features increase the odds of under staging T1 bladder cancer
    Alon Z Weizer
    Department of Urology, University of Michigan, Ann Arbor, Michigan, USA
    J Urol 182:59-65; discussion 65. 2009
    ..In this study we evaluated clinicopathological features to aid in the identification of patients with clinical T1 bladder cancer at risk for under staging...
  14. doi request reprint A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder
    Petros D Grivas
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
    Urology 82:111-7. 2013
    ..To assess the activity of neoadjuvant nab-paclitaxel, carboplatin, gemcitabine (ACaG) followed by cystectomy in patients with muscle-invasive urothelial carcinoma of the bladder...
  15. doi request reprint Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens
    Lakshmi P Kunju
    Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA
    J Urol 180:1928-32; discussion 1932. 2008
    ..We examined the agreement of lymphovascular invasion status in matched transurethral bladder tumor resection and cystectomy specimens...
  16. doi request reprint Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries
    Ted A Skolarus
    Department of Urology, Division of Oncology, University of Michigan, Ann Arbor, MI 48109, USA
    Urology 78:1345-9. 2011
    ..Restaging bladder tumor resection improves staging accuracy and the response to intravesical therapy. However, its use outside of a tertiary care setting, and its subsequent clinical implications, are unknown...
  17. doi request reprint Bladder cancer in 2010: how far have we come?
    Bruce L Jacobs
    Department of Urology, University of Pitsburgh School of Medicine, 3471 Fifth Avenue, Pittsburgh, PA 15213 3233, USA
    CA Cancer J Clin 60:244-72. 2010
    ..Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article...
  18. doi request reprint Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach
    Ajjai S Alva
    Division of Hematology Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Cancer 118:44-53. 2012
    ..The authors of this report hypothesized that a delay in cystectomy delivery after NAC is associated with adverse survival outcomes...
  19. doi request reprint Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer
    Scott M Gilbert
    Department of Urology, University of Florida College of Medicine, Gainesville, Florida, USA
    J Urol 183:1764-9. 2010
    ..We developed and validated a reliable, responsive multidimensional instrument to measure disease specific health related quality of life in bladder cancer survivors treated with local cancer therapy...
  20. ncbi request reprint Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI)
    Scott M Gilbert
    Department of Urology, Division of Health Services Research, University of Michigan, Ann Arbor, Michigan 48109 0759, USA
    Cancer 109:1756-62. 2007
    ....
  21. ncbi request reprint Radical cystectomy for bladder cancer after definitive prostate cancer treatment
    Timothy G Schuster
    Department of Urology, University of Michigan Hospitals, Ann Arbor, MI 48109 0330, USA
    Urology 61:342-7; discussion 347. 2003
    ..Radical cystectomy in these patients can be technically challenging and may be associated with added morbidity...
  22. ncbi request reprint Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy
    Alon Z Weizer
    Department of Urology, University of Michigan, Ann Arbor, MI 48109 0330, USA
    Urol Oncol 25:460-4. 2007
    ..Because concerns remain regarding incomplete surgical resection, we evaluated the risk of urothelial and prostate cancer in a series of patients undergoing radical cystoprostatectomy...
  23. doi request reprint Matched comparison of robotic-assisted and open radical cystectomy
    Nicholas R Styn
    Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, USA
    Urology 79:1303-8. 2012
    ..Although early results suggest that RARC is safe, with favorable perioperative and early oncologic outcomes, limited data exist comparing ORC and RARC...
  24. doi request reprint Delays in diagnosis and bladder cancer mortality
    Brent K Hollenbeck
    Department of Urology, Division of Oncology, University of Michigan Health System, Ann Arbor, MI, USA
    Cancer 116:5235-42. 2010
    ..Although screening currently is not recommended, better medical care of patients who are at risk (ie, those with hematuria) has the potential to improve outcomes...
  25. doi request reprint Identifying better practices for early-stage bladder cancer
    John Malcolm Hollingsworth
    Dow Division of Health Services Research, University of Michigan, Ann Arbor, MI, USA
    Med Care 49:1112-7. 2011
    ..Practice guidelines for nonmuscle invasive (ie, early stage) bladder cancer are ambiguous, resulting in substantial practice variation without a clear patient benefit...
  26. doi request reprint Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions
    Ryan C Hedgepeth
    Department of Urology, Division of Urologic Oncology, University of Michigan, Ann Arbor, Michigan, USA
    Urology 76:671-5. 2010
    ..The purpose of this study was to compare body image and quality of life between the 2 diversion types after surgery...
  27. ncbi request reprint Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer
    Michael Hu
    Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan
    Cancer 120:1409-16. 2014
    ..Readmissions after radical cystectomy are common, burdensome, and poorly understood. For these reasons, the authors conducted a population-based study that focused on the causes of and time to readmission after radical cystectomy...
  28. ncbi request reprint Gender and geographic influence on the racial disparity in bladder cancer mortality in the US
    Willie Underwood
    Department of Urology, University of Michigan, Ann Arbor, MI 48105, USA
    J Am Coll Surg 202:284-90. 2006
    ..The objective of this study was to evaluate the gender and geographic differences in bladder cancer survival between Caucasians and African Americans to better understand the racial disparity in bladder cancer survival...
  29. doi request reprint Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial
    Kevin S Oh
    Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, USA
    Int J Radiat Oncol Biol Phys 74:511-7. 2009
    ..We present the final analysis of bladder-intact survival (BIS), disease-specific survival (DSS), and overall survival (OS)...
  30. ncbi request reprint Comparison of modified Taguchi and Bricker ureteral reimplantation techniques after radical cystectomy
    Cheryl T Lee
    Department of Urology, University of Michigan, Ann Arbor, Michigan, USA
    Urology 64:940-4. 2004
    ..The modified Taguchi "single-stitch" ureteral reimplantation is reportedly a time-efficient technique that preserves anastomotic integrity...
  31. ncbi request reprint Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection
    Matthew J Wasco
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Urology 70:69-74. 2007
    ..This study examined the incidence, pathologic spectrum, and clinical significance of this phenomenon...
  32. ncbi request reprint -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro
    Jill A Macoska
    Department of Urology, The University of Michigan, Ann Arbor, MI 48109, United States
    Pharmacol Res 58:323-31. 2008
    ..Overall, these studies show that gossypol sensitizes bladder cancer cells to standard chemotherapeutic drugs and may provide a promising new strategy for bladder cancer treatment...
  33. ncbi request reprint Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer
    Alon Z Weizer
    Department of Urology, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Urol 177:1287-93. 2007
    ..This study examines patterns of treatment in this population and evaluates the impact of these factors on overall survival in a contemporary population...
  34. pmc Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer
    Rou Wang
    Department of Urology, Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan 48109 0944, USA
    Cancer Res 69:3810-8. 2009
    ..Thus, we identified a 57-gene QPCR panel to help predict progression of non-muscle-invasive bladder cancers and delineate a systematic, generalizable approach to converting microarray data into a multiplex assay for cancer progression...
  35. doi request reprint Summary of the 6th Annual Bladder Cancer Think Tank: new directions in urologic research
    Robert S Svatek
    Department of Urology, UT Health Science Center San Antonio, San Antonio, TX 78229, USA
    Urol Oncol 31:968-73. 2013
    ....
  36. doi request reprint Patterns of hematuria referral to urologists: does a gender disparity exist?
    Emilie K Johnson
    Department of Urology, University of Michigan, Ann Arbor, Michigan 48109, USA
    Urology 72:498-502; discussion 502-3. 2008
    ..However, little is known about the referral patterns of hematuria and whether gender differences exist...
  37. ncbi request reprint Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer
    Bernard H Bochner
    Department of Urology, Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, 1275 York Avenue, Kimmel Bldg, New York, NY 10021, USA
    Urol Clin North Am 30:777-89. 2003
    ..Because of the ever-increasing fiscal constraints placed on clinicians, risk-adjusted follow-up strategies are reasonable, but will require prospective evaluation to validate their appropriateness...
  38. ncbi request reprint Aggressive management of elderly patients with muscle-invasive bladder cancer
    Alon Z Weizer
    Department of Urology, University of Michigan, Ann Arbor, MI, USA
    Nat Clin Pract Urol 3:346-7. 2006
  39. pmc Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder
    David C Smith
    Department of Internal Medicine, Division of Hematology Oncology, University of Michigan School of Medicine, University of Michigan, Ann Arbor, Michigan, USA
    J Urol 180:2384-8; discussion 2388. 2008
    ..This 2-arm phase II multicenter trial was designed to assess the efficacy and toxicity of neoadjuvant paclitaxel, gemcitabine and carboplatin in patients with invasive bladder cancer...
  40. ncbi request reprint Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder
    Mark S Soloway
    Department of Urology, University of Miami Jackson Memorial Hospital, Miami, FL 33101, USA
    Urol Oncol 25:338-40. 2007
    ..Radical cystectomy as well as transurethral resection followed by intravesical BCG are acceptable initial therapies. This article reviews these treatment options and provides recommendations for management of high grade T1 tumors...
  41. pmc Racial differences in treatment and outcomes among patients with early stage bladder cancer
    Brent K Hollenbeck
    Division of Oncology, Department of Urology, University of Michigan, Ann Arbor, MI48109 0330, USA
    Cancer 116:50-6. 2010
    ..Alternatively, black patients may receive a lower quality of care, which may explain this difference...
  42. ncbi request reprint Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee
    Lisa A Newman
    Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
    Cancer 106:188-95. 2006
    ..Appropriate targets for accrual of minority ethnicity patients have not previously been defined...
  43. ncbi request reprint A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy
    Scott M Gilbert
    Department of Urology, University of Michigan, 7303 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0946, USA
    Nat Clin Pract Urol 3:675-9. 2006
    ..A 61-year-old woman with a substantial history of smoking presented with gross hematuria. Cystoscopic evaluation revealed a large bladder tumor...
  44. pmc Isolated recurrent renal cell carcinoma metastatic to the bladder
    Daya P Joshi
    Department of Urology, University of Michigan Hospitals, Ann Arbor 48109, USA
    J Natl Med Assoc 94:912-4. 2002
  45. doi request reprint Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Cancer 115:4096-103. 2009
    ....
  46. ncbi request reprint Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia
    Lakshmi P Kunju
    Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA
    Pathol Int 55:248-54. 2005
    ..In summary, abnormal CK20 is a useful adjunct to morphology for confirming dysplasia. Ki-67 by itself is a less reliable marker of dysplasia. E-Cad is not a useful marker in this setting...
  47. pmc Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression
    Stephanie Tseng-Rogenski
    Department of Urology, University of Michigan, 3875 Taubman Center Box 0330, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Am J Pathol 176:1462-8. 2010
    ..These data indicate that loss of PGDH expression contributes to a more malignant bladder cancer phenotype and may be necessary for bladder cancer development and/or progression...
  48. pmc HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease
    Pratima Tripathi
    Departments of Chemistry and Biophysics, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Proteome Res 12:3519-28. 2013
    ....
  49. ncbi request reprint Re: Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer
    Cheryl T Lee
    J Natl Cancer Inst 96:718-9. 2004
  50. ncbi request reprint Hautmann and Studer orthotopic neobladders: a contemporary experience
    Kyung Seop Lee
    Department of Urology, Dongguk University Hospital, Kyongju, Korea
    J Urol 169:2188-91. 2003
    ..Several series have promoted 1 technique over the other. We examine the clinical outcome of a contemporary cohort of patients with bladder cancer who underwent either Hautmann or Studer orthotopic reconstruction...